Loading…
Vilin Bio Med (VILINBIO)₹54.550.00%Pharmaceuticals
Vilin Bio Med is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 43.3 against a peer median of 17.1, and ROCE of 10.8% against a peer median of 11.5%, and latest-quarter sales growth of 215.6% against a peer median of 41.1%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cian Healthcare | 94 | — | −16.1 | −49.2 | 3.38 | 0.0 | 28 | −23 | 41.6 | — | vs VILINBIO |
| Vaishali Pharma | 91 | 23.4 | 7.9 | 6.0 | 0.28 | 0.0 | 109 | 4 | — | — | vs VILINBIO |
| Mercury Laboratories | 88 | 21.2 | 12.1 | 9.1 | 0.14 | 0.5 | 76 | 5 | −12.0 | −69.8 | vs VILINBIO |
| Amwill Health Care | 87 | 7.6 | 21.1 | 15.4 | 0.00 | 1.2 | 43 | 11 | 41.1 | 100.0 | vs VILINBIO |
| Jfl Life Sciences | 85 | 13.0 | 18.0 | 15.0 | 0.47 | 0.0 | 131 | 6 | −4.2 | 48.6 | vs VILINBIO |
| Denis Chem Lab | 83 | 10.0 | 14.0 | 9.6 | 0.05 | 2.5 | 182 | 8 | 13.1 | −43.1 | vs VILINBIO |
| Vilin Bio Med | 83 | 43.3 | 10.8 | 7.5 | 0.01 | 0.0 | 42 | 2 | 215.6 | 1,866.7 | — |
| Rekvina Labs | 81 | — | −333.3 | — | — | 0.0 | 1 | −0 | — | — | vs VILINBIO |
| Samrat Pharmachem | 80 | — | −3.0 | −4.8 | 0.16 | 0.4 | 289 | −3 | 0.7 | — | vs VILINBIO |
| Shelter Pharma | 76 | 8.3 | 20.4 | 15.1 | 0.01 | 0.8 | 73 | 9 | 49.8 | 22.2 | vs VILINBIO |
| Source Natural Foods & Herbal Supplements | 75 | 22.0 | — | — | — | 0.0 | 71 | 3 | 76.3 | 7.8 | vs VILINBIO |
| Peer median | 83 | 17.1 | 11.5 | 9.1 | 0.14 | 0.0 | 73 | 4 | 41.1 | 22.2 |
Listed companies closest to Vilin Bio Med in Pharmaceuticals include Cian Healthcare, Vaishali Pharma, Mercury Laboratories, Amwill Health Care, Jfl Life Sciences, Denis Chem Lab, Rekvina Labs, Samrat Pharmachem.
Cian Healthcare, with a market cap of ₹94.20 Cr.
Vilin Bio Med trades at a P/E of 43.3; the median of its peer set is 17.1. A P/E above or below the median is a description, not a judgement on value.
Vilin Bio Med's return on capital employed is 10.8%, below the peer median of 11.5%.